Clincosm LogoSign in Get a demo

myeloid leukemia, chronic

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Leukemia, Chronic Trial in Germany (dasatinib (SPRYCEL®))

Active, not recruiting
  • Myeloid Leukemia, Chronic
  • dasatinib (SPRYCEL®)
  • Aachen, Germany
  • +52 more
Jun 1, 2022

Myeloid Leukemia, Chronic Trial in France (Glivec)

Terminated
Has Results
  • Myeloid Leukemia, Chronic
  • Bordeaux, France
  • +6 more
Nov 5, 2021

Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

Recruiting
  • Myeloid Leukemia, Chronic
  • +8 more
  • Conventional T cells (Tcon) and Regulatory T cells (Treg)
  • Palo Alto, California
    Stanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021

Myeloid Leukemia, Chronic Trial in Berlin, Bremen (DC vaccine)

Recruiting
  • Myeloid Leukemia, Chronic
  • DC vaccine
  • Berlin, Germany
  • +1 more
Aug 3, 2021

Effect of 2nd Gen TKI in CML

Completed
  • Myeloid Leukemia, Chronic
    • Copenhagen, Denmark
    • +9 more
    Aug 14, 2019

    Myeloid Leukemia, Chronic Trial in Riyadh, Dammam (Nilotinib 300 mg.)

    Terminated
    • Myeloid Leukemia, Chronic
    • Nilotinib 300 mg.
    • Riyadh, Central, Saudi Arabia
    • +1 more
    Mar 6, 2017

    Myeloid Leukemia, Chronic Trial in Worldwide (Dasatinib, Imatinib)

    Completed
    Has Results
    • Myeloid Leukemia, Chronic
    • Portland, Oregon
    • +108 more
    Dec 22, 2016

    Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated-Phase, Blast Phase Trial in Houston (Homoharringtonine,

    Terminated
    Has Results
    • Myeloid Leukemia, Chronic
    • +3 more
    • Houston, Texas
      Univ. of Texas M.D. Anderson Cancer Center
    Jan 8, 2015

    Myeloid Leukemia, Chronic Trial in France (Imatinib ending)

    Completed
    • Myeloid Leukemia, Chronic
    • Imatinib ending
    • Angers Cedex 01, Angers, France
    • +23 more
    Jul 1, 2013

    Myeloid Leukemia, Chronic Trial in Japan (Dasatinib, dasatinib)

    Completed
    Has Results
    • Myeloid Leukemia, Chronic
    • Nagoya, Aichi, Japan
    • +8 more
    Nov 30, 2010